Health News Releases

August 12, 14:01

Align Technology Prevails in China Patent Infringement Action Against Angelalign

Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, today announced that the Jinan

August 11, 10:50

BeOne Medicines and Revolution Medicines Announce Clinical Development and Regional Commercialization Collaboration

BeOne Medicines Ltd (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fbeonemedicines.com%2F&esheet=54586664&newsitemid=20260810801799&lan=en-US&anchor=BeOne+Medicines+Ltd.&index=1&md5=

August 10, 10:50

ICC Arbitral Tribunal Issues Quantum Award for AOP Health in BESREMi® Proceedings

An ICC Arbitral Tribunal has awarded AOP Orphan Pharmaceuticals GmbH (“AOP Health”) a total of about EUR 112 Mio in a quantum award issued in the ongoing arbitration proceedings with PharmaEssentia Co

August 10, 08:00

Is a Lower SMILE LASIK Price Really the Best Choice? Three Things to Consider Beyond Cost

Dr. Se-Kwang Park, Chief Ophthalmologist at BGN Eye Clinic Jamsil, has advised patients on what to consider when selecting a clinic for SMILE LASIK surgery. For many people considering vision corre

August 07, 11:20

BeOne Medicines Announces Second Quarter 2026 Financial Results and Business Updates

BeOne Medicines Ltd. (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fbeonemedicines.com%2F&esheet=54583421&newsitemid=20260805570642&lan=en-US&anchor=BeOne+Medicines+Ltd.&index=1&md

August 06, 10:43

U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1

Takeda (TSE:4502/NYSE:TAK (https://www.takeda.com/investors/stock-information/)) announced that the U.S. Food and Drug Administration (FDA) approved (https://www.fda.gov/news-events/press-announcement

August 05, 14:30

WHOOP Expands Commitment to Women’s Health by Including One-Year Subscription of Natural Cycles° App in Membership

WHOOP (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.whoop.com%2F%3Fsrsltid%3DAfmBOoqrUNUmqB7UR9PSkcUqTlIlQZFv-cFnFEHe-4KarW-TDybGdsAu&esheet=54582456&newsitemid=20260804399367

August 05, 11:50

LabPMM® Launches Global KMT2A MRD Testing Service to Support Menin Inhibitor Development and Acute Leukemia Care

LabPMM®, an Invivoscribe® subsidiary, today announced the global availability of its new KMT2A measurable residual disease (MRD) testing service. The highly sensitive digital PCR service is available

August 04, 09:50

First Plus Expands Relationship with SS&C to Support Cross-Border Operations in APAC

SS&C Technologies Holdings, Inc. (https://www.ssctech.com/?utm_campaign=SSC2026-Enterprise-Press-Release-0826&utm_medium=pressrelease&utm_source=prnews&utm_content=First-Plus-SSNC) (Nasdaq: SSNC) toda

July 31, 13:40

White Paper Examines Early Clinical Development of B-Cell Depletion Therapies in Autoimmune Disease

Novotech, a leading global full-service clinical research organization (CRO) and scientific advisory company, has released a new white paper, B-Cell Depletion in Autoimmune Disease: Considerations for

July 30, 15:52

Takeda Announces FY2026 First Quarter Results, Near-Term Launch Preparations and Pipeline Progress on Track

Takeda (TOKYO:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Fstock-information%2F&esheet=54578194&newsitemid=20260727883646&lan=en-US&anc

July 30, 15:40

VDyne Announces First Patient Treated in TRIVITA US IDE Pivotal Study of the TriNova™ Transcatheter Tricuspid Valve Replacement System

VDyne Inc. (“VDyne”), a privately held medical device company developing an innovative transcatheter tricuspid valve replacement (TTVR) system, today announced that the first patient has been enrolled

July 30, 15:30

Copeland Enters into Exclusive Negotiations to Acquire Dickson, Advancing Cold Chain Leadership

Copeland, a global leader in compression technologies and controls solutions, today announced its entry into exclusive negotiations towards the purchase of Dickson, a portfolio company of May River Ca

July 30, 11:50

Xpress Genomics Joins Parse Biosciences’ Certified Service Provider Network

Parse Biosciences (https://www.parsebiosciences.com/), the leading provider of scalable and accessible single cell sequencing, and a QIAGEN company, today announced that Xpress Genomics (https://xpres

July 24, 16:41

Samsung Epis Holdings Reports Second Quarter and Half-Year 2026 Financial Results

Samsung Epis Holdings (KRX: 0126Z0), an investment company dedicated to innovations in biopharmaceuticals and biotechnology, today announced its financial results for the second quarter and first half

July 24, 11:15

Kirin and Blackmores Team Up to Release Cognitive Function Support Supplements in Australia and New Zealand Formulated with Kirin Group’s Cognizin® Citicoline

Kirin Holdings Company, Limited (Kirin Holdings)(TOKYO:2503) and Blackmores Limited (Blackmores), Kirin’s group company and Australia’s leading natural health company, are proud to announce the launch

July 23, 15:31

Galderma Reports Record First Half 2026 Net Sales of 3.134 Billion USD and 24.6% Year-on-Year Growth at Constant Currency, Raises Net Sales Guidance for the Full Year

Galderma Group AG (SIX: GALD), the pure-play dermatology category leader, today announced its financial results for the first half of 2026. · Net sales reached 3.134 billion USD, surpassing 3 billi

July 22, 11:30

Zayed Sustainability Prize’s Beyond2020 Initiative Strengthens Healthcare Resilience for Over 200,000 People in India

Beyond2020, the flagship initiative launched by the Zayed Sustainability Prize, the UAE’s pioneering award for innovative solutions to global challenges, today announced the deployment of solar-powere

July 21, 14:20

Brenus Pharma Welcomes New European and Asia-Pacific Life Sciences Investors in Series A Extension

Brenus Pharma today announced an €11 million ($12.6M) extension to its Series A round, bringing total capital raised since inception to €38 million ($43.5M). This funding reflects strong execution acr

July 21, 13:30

HistoSonics Opens Expanded Histotripsy Training Center in Hong Kong

HistoSonics today announced the opening of its expanded Histotripsy Training Center in Hong Kong, reinforcing the city’s position as a leading hub for physician education, clinical collaboration, and

July 21, 09:25

Clinigen Appoints Greg Skalicky as Chief Executive Officer

Clinigen, the global pharmaceutical services company dedicated to accelerating access to critical medicines worldwide, today announced the appointment of Greg Skalicky as Group Chief Executive Officer

July 20, 15:30

Galderma Launches Alastin® in Japan and Key Markets Across Asia Pacific, Expanding Its Footprint in the Region

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the launch of Alastin - its premium regenerative skincare brand - across the JPAC region. The brand recently launched i

July 19, 13:51

Aqemia and Sanofi Expand Their Research Collaboration

Aqemia, the drug invention company combining generative AI and quantum-inspired physics to invent small molecule drugs, today announced the expansion of its multi-year research collaboration with the

July 19, 13:30

Crown Bioscience Joins C-Path's NAMs Developer Coalition to Advance Human-Relevant Models in Drug Development

Crown Bioscience (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.crownbio.com%2F&esheet=54570432&newsitemid=20260716657544&lan=en-US&anchor=Crown+Bioscience&index=1&md5=de38f797

July 19, 13:05

Takeda’s Zasocitinib Demonstrates Consistent, High Rates of Skin Clearance Across the Body, Including Hard-to-Treat and High-Impact Sites, in Phase 3 Psoriasis Studies

Takeda (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Foverview%2F&esheet=54571620&newsitemid=20260716820927&lan=en-US&anchor=TSE%3A4

News by Region

News by Industry